Cerulean Pharma reported $117.8M in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adamis Pharmaceuticals ADMP:US 0.14B 0.02B
Agile Therapeutics AGRX:US $ 0.09B 0.03B
Arrowhead Research ARWR:US $ 6.51B 2.11B
Bayer BAYN:GR 46.18B 4.3B
Biocept BIOC:US $ 0.06B 0B
Brainstorm Cell Therapeutics BCLI:US $ 0.12B 0.02B
Cerulean Pharma CERU:US $ 0.12B 0.02B
Immunogen IMGN:US $ 1.18B 0.14B
Johnson & Johnson JNJ:US $ 425.15B 8.68B
Macrogenics MGNX:US $ 1.28B 0.34B
Merk MRK:US $ 190.13B 6.79B
Nektar Therapeutics NKTR:US $ 3.3B 0.17B
Perrigo Ordinary Shares PRGO:US 6.33B 0.21B
Pfizer PFE:US $ 241.14B 21.94B
Seattle Genetics SGEN:US $ 30.89B 2.24B
YTE INCY:US $ 15.19B 3.31B